ScanSource CEO exercises options, sells 77K shares
ScanSource’s CEO exercised 77,339 options at $37 and sold the resulting shares in open-market trades at weighted average prices in the mid‑$50s.
Rhea-AI Filing Summary
SCANSOURCE, INC. (SCSC) reported that Chief Executive Officer, President and Board Chair Michael L. Baur exercised vested employee stock options and sold the resulting shares. On September 10 and 11, 2026, he exercised options for a total of 77,339 shares of common stock at an exercise price of $37.00 per share and acquired the same number of shares.
On those same dates he sold an aggregate of 77,339 shares of common stock in open-market transactions at weighted average prices in the mid‑$50s per share, with the reported price ranges from about $55.07 to $58.61 depending on the trade group. No Rule 10b5-1 trading plan is reported for these transactions, and the filing does not state his resulting share ownership.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (Right to Buy) F6 | 57,359 | $0.00 | $0.00 |
| Exercise | Common Stock | 57,359 | $37.00 | $2.12M |
| Sale | Common Stock F3 | 1,851 | $56.50 | $105K |
| Sale | Common Stock F4 | 6,692 | $57.71 | $386K |
| Sale | Common Stock F5 | 48,816 | $58.14 | $2.84M |
| Exercise | Employee Stock Option (Right to Buy) F6 | 19,980 | $0.00 | $0.00 |
| Exercise | Common Stock | 19,980 | $37.00 | $739K |
| Sale | Common Stock F1 | 18,080 | $55.39 | $1.00M |
| Sale | Common Stock F2 | 1,900 | $57.03 | $108K |
Footnotes (6)
- F1. The price reported in column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $55.07 to $55.80 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F2. The price reported in column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $57.00 to $57.12 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3. The price reported in column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $55.92 to $56.87 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F4. The price reported in column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $56.96 to $57.94 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F5. The price reported in column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $57.96 to $58.61 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F6. The option vested in one-third increments on the anniversary of the grant date on 12/2/2017, 12/2/2018 and 12/2/2019.
Key Figures
Key Terms
Employee Stock Option financial
weighted average price financial
multiple transactions financial
grant date financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did SCSC’s CEO report on this Form 4?
What options did the CEO of SCSC exercise in this filing?
Were the SCSC insider sales made under a Rule 10b5-1 plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.